Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency

Álvaro Muñoz‐López(Josep Carreras Leukaemia Research Institute), Pablo Menéndez(Institució Catalana de Recerca i Estudis Avançats)

Stem Cell Reports

September 22, 2016

10.1016/j.stemcr.2016.08.013

Cited by 46

Related Papers

Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia

|Blood|2019|135

Feeder-free maintenance of hESCs in mesenchymal stem cell-conditioned media: distinct requirements for TGF-β and IGF-II

|Cell Research|2009|74

The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia

|Cancers|2022|4